Press Releases

Strategic Vision – Optimal Value

Investor Presentation

Cronos Group News

Cronos Group Provides Operational Update and Q3 Financial Results

Cronos Group Provides Operational Update and Q3 Financial Results

TORONTO, ON –November 29, 2016 NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE PharmaCan Capital Corp., doing business as Cronos Group (TSXV:MJN) (“Cronos” or the “Company”) is pleased to provide the first operational update related to its...

read more
Cronos Group Grants Stock Options

Cronos Group Grants Stock Options

TORONTO, ONTARIO--(Marketwired - Nov. 21, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp. doing business as Cronos Group ("Cronos Group" or the "Company") (TSX VENTURE:MJN) announces it has granted...

read more
Cronos Group Receives Liquidity From Non-Core Asset

Cronos Group Receives Liquidity From Non-Core Asset

TORONTO, ON--(Marketwired - November 01, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos Group" or "the Company"), has divested its equity...

read more
PharmaCan announces corporate rebranding to become Cronos Group

PharmaCan announces corporate rebranding to become Cronos Group

PharmaCan Capital today announced a corporate rebranding to Cronos Group. This rebranding reflects the new strategic vision of the Company as Canada’s first bi-coastal licensed cannabis producer with interests in five Licensed Producers (“LPs”) and three license applicants.

read more

76 Stafford Street, Suite 302

Toronto, Ontario M6J 2S1

Info@TheCronosGroup.com
Careers@TheCronosGroup.com

(416) 504-0004